ARTICLE SUMMARY:
Dan Burnett is demonstrating that, despite the decline in medtech venture capital, there are still ways of funding early-stage device companies, launching more than a dozen start-ups in nearly ten years.
Sometimes, being a contrarian pays off. In 2006, when Daniel Burnett, MD, launched TheraNova, a San Francisco-based medical device incubator, the medtech industry was flush with cash.
